Edition:
India

Vital Therapies Inc (VTL.OQ)

VTL.OQ on NASDAQ Stock Exchange Global Select Market

5.85USD
15 Jun 2018
Change (% chg)

$0.05 (+0.86%)
Prev Close
$5.80
Open
$5.80
Day's High
$5.90
Day's Low
$5.70
Volume
48,439
Avg. Vol
34,294
52-wk High
$7.20
52-wk Low
$2.45

Chart for

About

Vital Therapies, Inc. is a biotherapeutic company. The Company is focused on developing a human hepatic cell-based treatment targeting acute forms of liver failure. Its product candidate, the ELAD System, is an extracorporeal human allogeneic cellular liver therapy designed to allow the patient's liver to regenerate to a healthy... (more)

Overall

Beta: 5.35
Market Cap(Mil.): $249.02
Shares Outstanding(Mil.): 42.21
Dividend: --
Yield (%): --

Financials

BRIEF-Vital Therapies Q1 Loss Per Share $0.34

* VITAL THERAPIES ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

09 May 2018

BRIEF-Vital Therapies Announces VTL-308 Reaches Enrollment Target Of 150 Subjects

* VITAL THERAPIES ANNOUNCES VTL-308 REACHES ENROLLMENT TARGET OF 150 SUBJECTS

22 Mar 2018

BRIEF-Vital Therapies Announces Q4 Loss Per Share $0.35

* VITAL THERAPIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

14 Mar 2018

Earnings vs. Estimates